Follow on Google News News By Tag * Amd * Diabetic * Retinopathy * Drugs * Healthcare * Pharma * Market Research Reports * Aggregator * Company Profile * Company Insight * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News |  Macular Degeneration (AMD) and Diabetic Retinopathy Drugs Market through BharatbookBharatbook added a new report on "Macular Degeneration (AMD) and Diabetic Retinopathy Pharmaceutical Market 2010-2025" which gives Comprehensive analysis of the global AMD and DR sectors.
By: Bharatbook - what does the future hold for drugs to treat those disorders? Our new report examines current and future prospects for the age-related macular degeneration (AMD) and diabetic retinopathy (DR) pharmaceutical markets. The global market for AMD and DR drugs exceeded $2.5bn in 2009, with growth from previous years. We predict that the overall market will expand from 2010 onwards. The rising prevalence of AMD and DR is due to aging populations worldwide and other changes. In particular, the world is facing a "diabetes epidemic", with soaring numbers of people with diabetes and related complications, including diabetic retinopathy. ( http://www.bharatbook.com/ In particular, Macular Degeneration (AMD) and Diabetic Retinopathy Pharmaceutical Market 2010-2025 covers market prospects for the following agents: • Lucentis • Visudyne • Macugen • Avastin. Our report examines prospects for the retinal disorders market over the coming 15 years. The commercial success of Lucentis in treating wet AMD illustrates the high rewards for successful treatments. Our analyses reveal that there are commercial opportunities for the treatment of geographic atrophy (advanced dry AMD) and for wet AMD, among other disorders. There is a need for advantages over existing therapies, for improved clinical outcomes and ease of dosing. A large potential market for pharmacological treatment of diabetic retinopathy, AMD and other retinal disorders exists. Un-met and under-met therapeutic needs provide an impetus to drug developers, with high technological and commercial potential in this sector, our study reveals. What impact will monoclonal antibodies and steroid implants have on the future market? Which products are most likely to meet therapeutic needs in future years? Can newer therapies compete successfully with established treatments? How will Avastin affect the market share of Lucentis, and what are the implications for the future market? Our new report covers such questions, providing the information that you need. For more information kindly visit : http://www.bharatbook.com/ Related Reports Diabetic Retinopathy Therapy Area Pipeline Report http://www.bharatbook.com/ World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024 http://www.bharatbook.com/ Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/ Please visit our blog at http://bharatbookseo.blogsome.com # # # Bharat Book Bureau is the leading business information aggregator providing market research reports and online databases. Bharatbook is also into the business of marketing conferences worldwide and undertakes custom research. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number